Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Strategy for incorporating molecular and cytogenetic markers into acute myeloid leukemia therapy
Mark G Frattini, Peter G Maslak
Current Oncology Reports
|
August 21, 2007
Diagnosis and treatment of acute promyelocytic leukemia
Joseph G Jurcic, Steven L Soignet, And Peter G Maslak
Transfusion
|
March 11, 2021
A simplified CD34+ based preharvest prediction tool for HPC(A) collection
Reuben P Jacob, Eileen M Walsh, Peter G Maslak, et al.
Cancer
|
February 6, 2003
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin
Timothy B Aliff, Peter G Maslak, Joseph G Jurcic, et al.
Acta Haematologica
|
November 14, 2012
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia
Muhamed Baljevic, Omar Abdel-Wahab, Raajit Rampal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia
Mark A Weiss, Peter G Maslak, Joseph G Jurcic, et al.
Cancer
|
September 5, 2002
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia
Mark A Weiss, Timothy B Aliff, Martin S Tallman, et al.
Blood
|
January 25, 2008
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
Ping Zhou, Raymond L Comenzo, Adam B Olshen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Blood
|
April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
Peter G Maslak, Tao Dao, Lee M Krug, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Strategy for incorporating molecular and cytogenetic markers into acute myeloid leukemia therapy
Mark G Frattini, Peter G Maslak
Current Oncology Reports
|
August 21, 2007
Diagnosis and treatment of acute promyelocytic leukemia
Joseph G Jurcic, Steven L Soignet, And Peter G Maslak
Transfusion
|
March 11, 2021
A simplified CD34+ based preharvest prediction tool for HPC(A) collection
Reuben P Jacob, Eileen M Walsh, Peter G Maslak, et al.
Cancer
|
February 6, 2003
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin
Timothy B Aliff, Peter G Maslak, Joseph G Jurcic, et al.
Acta Haematologica
|
November 14, 2012
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia
Muhamed Baljevic, Omar Abdel-Wahab, Raajit Rampal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia
Mark A Weiss, Peter G Maslak, Joseph G Jurcic, et al.
Cancer
|
September 5, 2002
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia
Mark A Weiss, Timothy B Aliff, Martin S Tallman, et al.
Blood
|
January 25, 2008
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
Ping Zhou, Raymond L Comenzo, Adam B Olshen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Blood
|
April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
Peter G Maslak, Tao Dao, Lee M Krug, et al.
Page
of 2